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Abstract
Genetic diversity, especially at genes important for immune functioning within the Major Histocompatibility Complex
(MHC), has been associated with fitness-related traits, including disease resistance, in many species. Recently, genetic
diversity has been associated with mate preferences in humans. Here we asked whether these preferences are adaptive in
terms of obtaining healthier mates. We investigated whether genetic diversity (heterozygosity and standardized mean d
2)a t
MHC and nonMHC microsatellite loci, predicted health in 153 individuals. Individuals with greater allelic diversity (d
2)a t
nonMHC loci and at one MHC locus, linked to HLA-DRB1, reported fewer symptoms over a four-month period than
individuals with lower d
2. In contrast, there were no associations between MHC or nonMHC heterozygosity and health.
NonMHC-d
2 has previously been found to predict male preferences for female faces. Thus, the current findings suggest that
nonMHC diversity may play a role in both natural and sexual selection acting on human populations.
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Introduction
Positive associations between individual genetic diversity
(heterozygosity) and fitness-related traits are reported across many
taxa, although the effects are often weak, and the underlying
mechanisms are not well understood [1,2]. Coltman et al. [3]
proposed that genetic diversity could influence fitness through
disease resistance. Indeed, heterozygosity has sometimes been
associated with enhanced disease resistance in nonhuman animals
[3–7, but see 8]. Surprisingly little is known about the effect of
genome-wide heterozygosity on resistance to disease in humans,
but recently consanguinity, resulting in reduced heterozygosity,
was associated with increased susceptibility to two severe infectious
diseases, tuberculosis and hepatitis [9]. Reduced genome-wide
heterozygosity has also been associated with greater incidence of
non-infectious diseases such as high blood pressure, high
cholesterol levels, stroke, and asthma [10,11]. Thus, there is some
evidence that heterozygosity is beneficial for human health.
Heterozygosity at genes within the MHC (or human leukocyte
antigen, HLA, in humans) may be especially important for
enhanced immune functioning, and therefore health [12–14].
MHC alleles encode peptides that bind to and present a restricted
range of foreign antigen-peptides to T-cells, thereby initiating a
rapid immune response [15]. Because MHC alleles are expressed
codominantly, MHC heterozygotes should be able to detect a
broader range of pathogens than homozygotes [12,16,17].
Despite being strongly predicted by theory, evidence for a MHC
heterozygote advantage is equivocal [e.g. 14,18,19]. A MHC
heterozygote advantage has been found in non-human animals for
multiple infections [20–25], and in humans, for resistance to
specific complex viral infections and parasites [26–29, but see 30].
In addition, some studies report an advantage for an intermediate
level of MHC diversity in non-mammalian species [31–33],
whereas other studies report no heterozygote advantage, but
MHC allele-specific resistance against specific pathogens [34–38].
These mixed findings might reflect experimental design rather
than a lack of heterozygote advantage per se, because resistance is
allele specific and many studies test resistance towards only one or
a few pathogens [18]. Thus, heterozygote advantage may only be
apparent in the context of infections by multiple pathogens
[18,25].
As well as influencing individual fitness, heterozygosity, both
within the MHC and in general, appears to play a role in sexual
selection [2,39]. Provided heterozygosity is associated with
enhanced fitness, preferences for heterozygosity in a mate should
be adaptive. If heterozygous individuals are healthy, then a
heterozygous mate could potentially enhance offspring viability
directly, through reduced risk of contagion or better provisioning
of resources and parental care [40], and indirectly, because
heterozygosity is on average heritable [41,42].
There is evidence that heterozygosity, especially at the MHC, is
preferred in a mate [reviewed in 2,39]. For example, female fur
seals (Arctocephalus gazella) actively choose more heterozygous mates
[42]. Female fat-tailed lemurs (Cheirogaleus medius) prefer genome-
wide and MHC heterozygosity in their mates [43], and MHC
heterozygosity is the best predictor of reproductive success in
macaques (Macaca mulatta) [44]. Recent studies in humans have
found that females prefer the faces [45,46, but see 47] and the
axillary odour [47] of MHC-heterozygous males. Moreover, males
preferred the faces of females with greater general genetic
diversity, measured as standardized mean d
2 (reflecting genetic
distance between parental genomes) at loci outside the MHC [46,
H. Lie, L. W. Simmons, & G. Rhodes, unpublished data].
An association between genetic diversity and health would
provide evidence that preferences for genetic diversity in a
potential mate might be adaptive. Here, we test whether genetic
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‘‘everyday’’ health, measured broadly as symptoms of common
infectious diseases. Number of self-reported symptoms has been
validated as a proxy measure of presence of infectious diseases
[48], and has been used previously [e.g. 49,50,51]. Susceptibility
to infectious diseases has commonly been measured by retrospec-
tive, self-report questionnaires, often requiring recall of illness
episodes or symptoms that may have occurred in the last year,
three years, or even over an individual’s lifetime [e.g. 30,52,53].
Because recalling illness events over such long periods is subject to
memory and reporting biases, we use a longitudinal design
measuring health over a four-month period to reduce the influence
of such biases on health reporting. Moreover, because health
differences between more and less heterozygous individuals could
be difficult to detect in a sample of university students in a modern
society, the four-month health survey included a stressful exam
period to potentially enhance individual differences in susceptibil-
ity to common infectious diseases. Elevated stress levels, associated
with stressful events such as exam periods, are well known to
compromise immune functioning, and increase rates of infectious
diseases in students [54,55].
To examine whether genetic diversity in general and/or at the
MHC is associated with health, we used microsatellite markers at
loci within and outside the MHC. We calculated two measures of
individual genetic diversity: multilocus heterozygosity (referred to
as H) and standardized mean d
2 (referred to as d
2), which reflect
the proportion of heterozygous loci and the average genetic
distance between alleles within an individual respectively. Mean d
2
has been criticised for being less sensitive to genetic diversity-
fitness correlations than heterozygosity [e.g. 56], and conditions
where mean d
2 is expected to outperform heterozygosity are
poorly defined [56–58]. However, some studies have found mean
d
2 to predict different aspects of individual fitness than heterozy-
gosity [e.g. 7,59,60], or to predict fitness-related traits when there
was no effect of heterozygosity [60–63]. We therefore included
both measures of genetic diversity.
Microsatellites are assumed not to be subject to selection.
However, microsatellites embedded within the MHC are increas-
ingly being used to infer levels of MHC diversity, as they typically
show evidence of selection acting on the MHC loci to which they
are linked [e.g. 64,65,66]. The MHC microsatellites used here are
known to be in linkage with MHC Class I, II, and III genes [67].
In addition, these microsatellites span a relatively large section of
the MHC compared to the 2–5 MHC loci typically sampled in
past research [27,28,30]. The nonMHC loci were chosen to be
qualitatively similar to the MHC loci. Because the nonMHC loci
were highly polymorphic, they are likely to be in linkage with
nearby functional loci under balancing selection [68,69]. Thus,
our measures of microsatellite diversity should reflect genetic
diversity at functional loci across the MHC, and in general.
In summary, we investigated whether individuals with greater
genetic diversity (H and d
2) in general and/or at the MHC report
better ‘‘everyday’’ health over a four-month period than less
genetically diverse individuals. We previously found that genetic
diversity predicted mate preferences in the same sample. If genetic
diversity predicts health, then this would suggest that the observed
preference for genetically diverse individuals is adaptive.
Methods
Ethics statement
Procedures were approved by the university’s Human Research
Ethics Committee (project number RA/4/1/1292), and each
participant provided written informed consent.
Participants
The sample consisted of 153 white Caucasian students at the
University of Western Australia (77 females, mean age 19.5, SD
2.5; 76 males, mean age 20.4, SD 3.2, for details see Lie et al.
2008). Each participant provided written informed consent, a
DNA-sample, and completed several questionnaires in return for
course credit and/or 10 Australian dollars.
DNA samples and genetic diversity measures
The procedures for DNA collection and genetic analyses are
described in full elsewhere (Lie et al. 2008). Briefly, MHC diversity
was measured using 12 microsatellite markers (average number of
alleles: 12, and heterozygosity: 0.83) across the MHC region, all of
which are in linkage disequilibrium with one or more MHC genes
[67]. General genetic diversity (nonMHC) was measured using 11
microsatellite markers (average number of alleles: 14, and
heterozygosity: 0.84) located on 11 different chromosomes. All loci
were in Hardy-Weinberg equilibrium (Lie et al. 2008). Genetic
diversity was measured using Heterozygosity (H), calculated as the
proportion of heterozygous loci within an individual, and a
standardized version of mean d
2 [59]. Here, d
2 is the squared
difference in number of repeat units between the two alleles at a
given locus, standardized by the maximum observed value at that
locus,andaveragedacrossallmeasuredloci[see 46,63,70].Weused
the standardized version of mean d
2 to reduce undue influence of
loci with large allelic size ranges on the arithmetic mean of the
measure [70]. The resulting values range from zero to one.
Provided microsatellites evolve under the stepwise mutation
model [71,72], mean d
2 should reflect genetic distance between
parental genomes. Greater d
2 values indicate longer time since
coalescence and higher levels of outbreeding, while greater values of
heterozygosity should better reflect lower levels of inbreeding [73].
Health measure
Health was measured broadly as the number of symptoms of
infectious diseases reported prospectively over a four-month
period. Every fortnight, participants completed an online symptom
checklist where they indicated which, if any, symptoms they had
experienced that fortnight. Symptom included: sore throat, cough,
runny or stuffy nose, fever, sinus pain, ear pain, itchy, irritated or
runny eyes, vomiting. The participants were asked not to report
symptoms due to allergies such as hay-fever. The number of
symptoms reported each fortnight was summed and averaged
across number of surveys completed for each participant (134
participants completed all eight, 14 completed seven, three
completed six, and two participants completed five). Thus a
higher score on the health measure reflects a higher average
number of symptoms (worse health) reported each fortnight.
A range of potentially confounding variables that can influence
susceptibility to infectious diseases was also measured by
questionnaires, fortnightly over the four-month period. Stress
has a negative impact on immune functioning [54], and was
measured using the stress-subscale from the Depression, Anxiety
and Stress Scales [DASS 21; 74]. A higher score indicates more
stress (range 0–42). Negative affect (NA), a personality trait
capturing individual differences in experiencing negative moods,
has been found to significantly bias self-report of symptoms [75],
and was measured using Stokes and Levin’s [76] Negative Affect
scale. A higher score indicates higher levels of NA (range 0–147).
Participants also reported any of their behaviours that they felt had
compromised their health (e.g. excessive drinking, smoking, taking
drugs, lack of sleep). Because exercise can affect immune
functioning [77], we calculated average amount of self-reported
exercise per fortnight (hrs, mins) per participant. Additionally,
Genetic Diversity and Health
PLoS ONE | www.plosone.org 2 July 2009 | Volume 4 | Issue 7 | e6391Socio-Economic Status (SES), commonly associated with health
[78], was measured by scoring both parents occupation according
to the Australian Standard Classification of Occupations (ASCO,
Australian Bureau of Statistics, 2
nd edition, 1997) [79]. The lowest
score (indicating higher SES) obtained from either parent was used
as the SES measure. Lastly, age was included as a potential
covariate, because age influences immunity [80].
Results
The health measure (average number of symptoms) was square-
root transformed to achieve normality. All other distributions were
skewed, but left untransformed as some could not be transformed
to normality. Descriptive statistics for all variables are presented in
Table 1, and Pearson’s product-moment and Spearman rho
correlation coefficients are presented in Table S1 of the online
supporting information.
The correlations in Table S1 indicated that the nonMHC-H and
-d
2 measures and the MHC-H and -d
2 measures were significantly,
positively correlated (all r.0.3). Moreover, the health measure was
associated with several of the covariates. We therefore fitted initial
multiple regression models by simultaneously entering all potential
covariates as well as a gender term, nonMHC and MHC diversity,
and interaction terms between the gender and diversity measures
(Table S2 and S3 of the online supporting information). Although
the predictor variables were not normally distributed, the
transformed outcome variable, health, was. To ensure that the
data was suitable for regression analysis, we checked the normality
of residuals and forthepresence of outliers with high leverage values
in the final models. The models were simplified by sequential
deletion of non-significant variables. Significant covariates retained
in the final models were age, stress and non-healthy behaviours.
Increased age predicted fewer symptoms, while increased stress
levels and non-healthy behaviours predicted more symptoms
reported. No other covariates or interaction terms were significant.
Because gender did not interact with genetic diversity, male and
female data were combined for further analyses.
With the significant covariates established, we then used
hierarchical multiple regression models to investigate whether genetic
diversity predicted health (number of symptoms) after controlling for
the covariates. Hierarchical regression allows us to examine whether
genetic diversity (H and d
2) has an effect on health over and above the
effect of the covariates by entering the covariates in the first block and
the genetic diversity variables in subsequent blocks. Additionally, we
enterednonMHCdiversityinthesecondblockandMHCdiversityin
the third block to examine whether MHC diversity influenced health
when controlling for nonMHC diversity.
We found no relationship between either nonMHC-H or
MHC-H and health after adjusting for covariates (Table 2). There
was, however, a small, but significant, effect of nonMHC-d
2 on
health, with individuals with greater nonMHC-d
2 reporting fewer
symptoms (better health) over the four-month period (Table 3). In
addition, there was also a small independent effect of MHC-d
2 on
health after controlling for the effect of nonMHC-d
2, with
individuals with greater MHC-d
2 reporting fewer symptoms.
To test whether some or all of the nonMHC and MHC loci
sampled contributed to the observed effects, we conducted single-
locus analyses (see Lie et al. 2008), using consecutive hierarchical
multiple regression models. As in the other models, we adjusted for
gender, age, stress and non-healthy behaviours. In each model the
predictors were d
2 at a single locus and a measure of d
2 calculated
across all remaining loci, omitting the locus under consideration.
No single locus disproportionally influenced the observed effect of
nonMHC-d
2 on health, and the removal of any one locus did not
substantially reduce the p-value for the effect of nonMHC-d
2
calculated across the remaining loci (Table 4).
The effect of MHC-d
2 on health, however, was influenced by one
locusinparticular,D6S2883(p=0.005,Table4),and theeffectofthe
remaining loci combined was substantially reduced on its removal
(p.0.60). However, the effect of this locus would not survive
Bonferroni correction for multiple comparisons (corrected p=0.004).
Discussion
These results provide some support for an association between
genetic diversity and a measure of general, everyday health in
humans. We found a small, but significant, effect of nonMHC
genetic diversity, measured as standardized mean-d
2, on health.
Individuals with greater nonMHC-d
2 reported significantly fewer
symptoms over a four-month period than less diverse individuals,
with nonMHC-d
2 accounting for 3% of the variance in health.
This relationship suggests that the previously observed male
preferences for the faces of females with high levels of nonMHC-d
2
would be adaptive for obtaining a healthier mate [46].
That nonMHC-d
2 is associated with health, a fitness-related
trait, is consistent with several studies in non-human animals that
report weak, positive relationships between genetic diversity
(measured as mean d
2) at neutral markers and fitness-related traits
[7,59,61,62,73]. Although little is known about the effect of genetic
diversity on disease resistance in humans, there is evidence that
reduced genome-wide heterozygosity increases the risk of two
severe infectious diseases, tuberculosis and hepatitis [9], and
increases the incidence of a range of non-infectious diseases
[10,11]. Thus our results add to the evidence for a beneficial effect
of genetic diversity on health in humans.
There was also a small effect of MHC-d
2 on health, with MHC-
d
2 accounting for 2% of the variance in health. Unlike the effect of
nonMHC-d
2, this effect was mainly driven by allelic diversity (d
2)
at one locus, D6S2883. D6S2883 is in strong linkage with the
MHC class II gene HLA-DRB1 [67], and heterozygosity at HLA-
DRB1 has been implicated in resistance to both viral and parasite
infections in humans [26,27,29]. However, the effect of the single
locus did not survive correction for multiple comparisons,
therefore leaving the statistical significance of this finding
uncertain. Replication of this finding is clearly needed before
Table 1. Descriptive statistics for the health (number of
symptoms), covariate and the genetic diversity variables
(n=153).
Variable Mean (SD) Median (Range)
Health* 1.07 (0.43) 1.06 (0.00–2.12)
Age 19.92 (2.91) 19.00 (18.00–33.00)
SES 2.62 (1.51) 2.00 (1.00–8.00)
NA* 69.12 (19.37) 68.57 (30.68–115.14)
Stress* 10.64 (6.56) 9.50 (0.00–29.43)
Non-Healthy Behaviour* 0.41 (0.37) 0.29 (0.00–1.14)
nonMHC-H 0.84 (0.12) 0.82 (0.55–1.00)
MHC-H 0.84 (0.12) 0.83 (0.50–1.00)
nonMHC-d
2 0.16 (0.07) 0.16 (0.04–0.40)
MHC- d
2 0.17 (0.07) 0.17 (0.05–0.35)
*Measures are averages from data collected once a fortnight for a four-month
period.
doi:10.1371/journal.pone.0006391.t001
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could explore the role of Class II diversity, especially HLA-DRB1,
in susceptibility to common infectious diseases such as upper-
respiratory tract infections.
We found no effect of the heterozygosity measures on health.
The discrepancy in the associations between the H and the d
2
measures and health may be a result of several factors. First,
standardized mean d
2 has intrinsically higher variance and greater
Table 3. Hierarchical multiple regression model predicting health (number of symptoms) using nonMHC and MHC standardized
mean d
2 (d
2) measures, while controlling for covariates.
Block with predictors B (695 CIs) SE b tp R
2 DR
2
Block 1
Age 20.03 (20.05–20.01) 0.01 20.21 22.73 0.007 0.15**
Stress 0.02 (0.01–0.03) 0.01 0.25 3.33 0.001
Non-healthy behaviour 0.21 (0.04–0.39) 0.09 0.18 2.42 0.017
Block 2
Age 20.03 (20.06–20.01) 0.01 20.22 22.94 0.004 0.18** 0.03*
Stress 0.02 (0.01–0.03) 0.01 0.25 3.32 0.001
Non-healthy behaviour 0.20 (0.03–0.37) 0.09 0.17 2.27 0.024
nonMHC-d
2 21.17 (22.14–20.20) 0.49 20.18 22.38 0.019
{
Block 3
Age 20.03 (0.05–20.01) 0.01 20.20 22.59 0.011 0.20** 0.02*
Stress 0.02 (0.01–0.03) 0.01 0.24 3.27 0.001
Non-healthy behaviour 0.20 (0.03–0.037) 0.09 0.17 2.33 0.021
nonMHC-d
2 21.11 (22.07–20.15) 0.49 20.17 22.28 0.024
MHC-d
2 20.98 (21.95–20.00) 0.49 20.15 21.98 0.049
{
Covariates were entered in block 1 to investigate whether genetic diversity had an effect on health over and above the effect of the covariates. NonMHC-d
2 was entered
in block 2 to examine whether MHC-d
2 had an effect on health over and above the effect of nonMHC-d
2 (n=153). See notes below for effect sizes and 95% confidence
intervals.
Notes: Overall model: F5,147=7.27, p,0.001.
**p,0.05, **p,0.001
Effect sizes:
{nonMHC-d
2: r (95% CI)=20.19 (20.34–20.04),
{MHC-d
2: r (95% CI)=20.16 (20.31–20.003).
doi:10.1371/journal.pone.0006391.t003
Table 2. Hierarchical multiple regression model predicting health (number of symptoms) using nonMHC and MHC heterozygosity
(H) measures, while controlling for covariates.
Blocks B (695 CIs) SE b tp R
2 DR
2
Block 1
Age 20.03 (20.05–20.01) 0.01 20.21 22.73 0.007 0.15***
Stress 0.02 (0.01–0.03) 0.01 0.25 3.33 0.001
Non-healthy behaviour 0.21 (0.04–0.39) 0.09 0.18 2.42 0.017
Block 2
Age 20.03 (20.06–20.01) 0.01 20.21 22.66 0.009 0.15*** 0.00
Stress 0.02 (0.01–0.03) 0.01 0.26 3.33 0.001
Non-healthy behaviour 0.22 (0.04–0.39) 0.09 0.19 2.42 0.017
nonMHC-H 0.08 (20.47–0.62) 0.28 0.02 0.28 0.779
Block 3
Age 20.03 (0.06–20.01) 0.01 20.22 22.83 0.005 0.16*** 0.01
Stress 0.02 (0.01–0.03) 0.01 0.26 3.36 0.001
Non-healthy behaviour 0.21 (0.04–0.039) 0.09 0.18 2.37 0.019
nonMHC-H 0.02 (20.53–0.57) 0.28 0.01 0.08 0.936
MHC-H 0.41 (20.12–0.93) 0.27 0.12 1.52 0.130
Covariates were entered in block 1 to investigate whether genetic diversity had an effect on health over and above the effect of the covariates. NonMHC-H was entered
in block 2 to examine whether MHC-H had an effect on health over and above the effect of nonMHC-H (n=153).
Notes: Overall model: F5,147=5.56, p,0.001.
***p,0.001.
doi:10.1371/journal.pone.0006391.t002
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small number of loci [1], which may explain some of the observed
differences in associations with health.
Second, some researchers argue that heterozygosity is more
sensitive to genetic diversity–fitness associations than mean d
2,
because heterozygosity tends to correlate more highly with known
inbreeding coefficients than mean d
2 [57,58,70,81]. By contrast,
others have argued that under certain circumstances, mean d
2
measures can be more sensitive to diversity–fitness associations
than heterozygosity, when highly variable markers are used in
large outbred populations, and there is low levels of variation in
heterozygosity but considerable variation in mean d
2 [60,63,82].
Here, heterozygosity levels were high across all individuals, and
we used highly variable markers. Thus, increased allelic distance
(captured by d
2, but not H) may capture fitness benefits associated
with health not explained by heterozygosity. For example, the d
2-
health relationship may reflect an outbreeding advantage, where
greater allelic divergence predicts better health, rather than a
selection against homozygotes [e.g. 61].
Lastly, although the two measures correlate positively (r.0.30),
they appear to be sensitive to different aspects of phenotypic
quality in humans (e.g. MHC-H, but not d
2, predicts male facial
attractiveness, while nonMHC-d
2, but not H, predicts health and
female attractiveness). Thus, more research is needed to better
understand how and why H and d
2 predict fitness-related traits
differently within the same individual.
Although we measured genetic diversity using microsatellites
assumed to be selectively neutral, the MHC markers used here are
known to be in linkage with MHC genes [67]. In addition, the
nonMHC markers were highly polymorphic and therefore likely to
be in linkage with functional loci under balancing selection [e.g.
68,69]. Thus diversity at the microsatellites should reflect genetic
diversity across the MHC and in general (nonMHC). The effects
of nonMHC-d
2 on health did not appear to be unduly influenced
by any one locus, while only one MHC locus contributed to the
observed effect of MHC-d
2 on health.
From a sexual selection perspective, our finding that nonMHC-
d
2 was associated with health provides some of the first evidence
that genetic diversity outside the MHC is beneficial for the
individual. This finding also suggests that male preferences for
greater nonMHC-d
2 in females are adaptive. On the other hand,
females prefer the faces of males who are MHC heterozygous
[45,46], but we found no association between MHC diversity and
our measure of health. We cannot, however, conclude that the
observed MHC heterozygosity preference is not adaptive because
our health measure is by no means a comprehensive measure of
mate quality, and there is good evidence that MHC heterozygosity
is associated with greater resistance to diseases in humans [26–29].
In an attempt to capture individual differences in ‘‘everyday
health’’, our measure of health consisted of self-reported symptoms
associated with common infectious diseases, such as upper-
respiratory tract infections. Although a medical doctor did not
verify the reported symptoms, Larson et al. [48] found that in 93
of 100 cases, the self-reported symptoms were confirmed by a
doctor. They concluded that self-report of symptoms was an
acceptable proxy measure of the presence of infectious diseases.
Our health measure improved upon commonly used retrospective
self-report measures [e.g. 30,52,53] by using a longitudinal design
to reduce biases associated with self-report of symptoms. This
design should improve reporting accuracy because the recall
periods are short (two weeks only), and the participants are aware
that they need to monitor and report their symptoms. In addition,
we also controlled for variables that can impact on reporting of
and susceptibility to infectious diseases such as negative affect and
stress. Controlling for such covariates should reduce the variance
in symptom reporting that is due to false alarms such as
psychosomatic conditions without any infectious background.
Despite the relatively brief period surveyed (four months) and
modest sample size, we still found significant effects of one
measure of genetic diversity on ‘‘everyday health’’ in our student
sample. Including an exam period, a stressful event known to
compromise immunocompetence [54,55], may have increased our
ability to detect a genetic diversity-health relationship. Our effect
sizes (r 20.16 and 20.19) compare favourably with those typically
reported for heterozygosity-fitness associations (mean r.0.10) [1],
and are consistent with the range of effect sizes normally reported
in evolutionary and ecological research (r’s between 0.18–0.19)
[83]. Thus, prospective health surveys, even over relatively short
Table 4. Test for the effect of single locus d
2 and general d
2 (calculated using all loci but excluding the locus being considered)
effects on health (number of symptoms) shown separately for nonMHC and MHC loci (n=153).
nonMHC-d
2 MHC-d
2
Loci Single locus p General p Loci Single locus p General p
D1S218 0.367 0.035 D6S276 0.508 0.192
D2S2382 0.567 0.031 D6S2863 0.710 0.133
D4S413 0.078 0.038 D6S510 0.598 0.116
D6S441 0.994 0.016 D6S265 0.164 0.028
D8S550 0.814 0.014 D6S2811 0.634 0.091
D10S191 0.150 0.080 D6S2810 0.782 0.130
D12S345 0.910 0.014 D6S2792 0.734 0.152
D14S283 0.058 0.071 D6S2787 0.497 0.133
D16S515 0.032 0.003 D6S2894 0.655 0.238
D18S61 0.584 0.024 D6S2883 0.005 0.608
D20S117 0.196 0.038 D6S2876 0.827 0.153
D6S291 0.511 0.069
Table shows p-values for the single locus (single) and all remaining loci combined (general).
doi:10.1371/journal.pone.0006391.t004
Genetic Diversity and Health
PLoS ONE | www.plosone.org 5 July 2009 | Volume 4 | Issue 7 | e6391time periods, may be a promising avenue to further investigate
relationships between genetic diversity and health in humans.
In conclusion, our results provide mixed evidence for an
association between genetic diversity and ‘‘everyday health’’ in
humans. Standardized mean d
2, but not heterozygosity, at
nonMHC loci predicted fewer symptoms reported over a four-
month period. Previously, we found that the same measure of
genetic diversity predicted facial attractiveness of the same females
[46]. Combined, these findings suggest that this preference may be
adaptive. Future research should investigate the relative merits of
using standardized mean d
2 and heterozygosity as measures of
genetic diversity when investigating the role of genetic diversity in
natural and sexual selection acting on human populations.
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